New

Fresenius Kabi

The AI engine Fit Assessment

Beta

The company will be attending the 2024 Health Tech Forward Event

Blurb

Fresenius Kabi Austria is a healthcare firm that produces intravenous administered generic drugs, infusion therapy, and clinical nutrition.

HQ Location

Germany

Founded

1999

Employees

+10000

Total funding raised

Not available

Last Funding Event

Not available

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M

Operator of a healthcare company intended to offer biosimilar drugs with a focus on autoimmune diseases and oncology. The company specializes in complex biopharmaceuticals, lifesaving medicines, I.V. generic drugs, and technologies for infusion, transfusion, and clinical nutrition.